Published in Indian Journal of Endocrinology and Metabolism, the study finds that patients without diabetes lost more than double the weight compared to those with the condition.
Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.
As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.
India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.
Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended alongside a controlled diet and regular physical activity.
India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to transform access to weight-loss treatment.
Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS